Clinical Trials on Bullous Pemphigoid in France

Total 56 results

University Hospital, Rouen
Société de Dermatologie Française

Unknown

Evaluation of Fluid Retention Due to Superpotent Topical Corticosteroid (RECOPB)

Bullous Pemphigoid

France
CHU de Reims

Completed

Interest of Dosage of Anti-PB230, Anti-PB180 and Cytokines for Monitoring of Patients Suffering From Bullous Pemphigoid (Cyto-PB)

Bullous Pemphigoid

France
CHU de Reims

Completed

Efficacy and Safety of Ustekinumab in Bullous Pemphigoid (PB-USTE)

Bullous Pemphigoid

France
University Hospital, Montpellier

Completed

Topical Steroids Alone or Associated With Methotrexate in Bullous Pemphigoid (BP/MTX)

Bullous Pemphigoid

France
University Hospital, Rouen

Completed

Efficiency and Tolerance of Rituximab (mabthéra) in Bullous Pemphigoid (Rituximab2)

Bullous Pemphigoid

France
Assistance Publique Hopitaux De Marseille

Unknown

Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid?

Bullous Pemphigoid

France
University Hospital, Limoges

Unknown

Leflunomide Associated With Topical Corticosteroids for Bullous Pemphigoid (ARABUL)

Bullous Pemphigoid

France
University Hospital, Rouen

Completed

Comparison of Two Therapeutic Strategies of Dermoval in Treatment of Bullous Pemphigus

Bullous Pemphigoid

France
University Hospital, Rouen

Not yet recruiting

Validation of a Simplified Severity Score (Investigator Global Assessment: IGA) in Bullous Pemphigoid (IGA score)

Bullous Pemphigoid

France
CHU de Reims

Completed

Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid (EDP-PB)

Bullous Pemphigoid

France
Centre Hospitalier Universitaire de Nice

Completed

Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody (IPH)

Bullous Pemphigoid

France
University Hospital, Limoges

Completed

Pharmacokinetics Study of Mycophenolic Acid in Patients With an Autoimmune Bullous Dermatose, Pemphigus or Cicatricial Pemphigoid. (PEMPA)

Autoimmune Bullous Dermatose

France
CHU de Reims

Completed

Impact of Neurological Diseases on the Prognosis of Bullous Pemphigoid: A Retrospective Study of 178 Patients

Bullous Pemphigoid

France
Novartis Pharmaceuticals

Terminated

Safety, Efficacy and PK/PD of QGE031 vs. Placebo in Patients With Active Bullous Pemphigoid Despite Oral Steroid Treatment

Bullous Pemphigoid

Taiwan, Germany, United States, Japan, Austria, France
Centre Hospitalier Universitaire de Nice

Completed

Study of the Periodontal Microbiota in Gingival Cicatricial Pemphigoid Patients. Bicentric Pilot Study.

Pemphigoid

France
University Hospital, Bordeaux

Recruiting

Screening for Adrenal Insufficiency During Dermocorticoid Reduction in Bullous Pemphigoid (BP) (PB-DEPIST)

Pemphigoid, Bullous | Adrenal Insufficiency

France
Centre Hospitalier Universitaire, Amiens
University Hospital, Rouen

Recruiting

Influence of Dermocorticoids on Bone Mineral Density in Patients With Bullous Pemphigoid (DERMOS)

Osteoporosis | Bullous Pemphigoid

France
Nantes University Hospital

Unknown

Bullous Pemphigoid Induced by antiPD-1/PDL-1 Therapy

Bullous Pemphigoid | Immunotherapy | Programmed Cell Death Ligand 1

France
CHU de Reims

Unknown

Genetic Susceptibility and Influence of the Microbiomae in Bullous Pemphigoid (MICROPB)

Bullous Pemphigoid

France
Regeneron Pharmaceuticals
Sanofi

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid (LIBERTY-BP)

Bullous Pemphigoid

United States, Japan, Germany, Australia, France, Israel, Poland, Spain, Taiwan
argenx

Active, not recruiting

A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid (BALLAD)

Bullous Pemphigoid

United States, Australia, Bulgaria, China, Croatia, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Latvia, Netherlands, Poland, Romania, Serbia, Slovakia, Spain, United Kingdom
University Hospital, Rouen

Recruiting

Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid (RITUX-MMP)

Severe Forms of Mucous Membrane Pemphigoid

France
Centre Hospitalier Universitaire de Nīmes

Terminated

Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid

Pemphigoid, Bullous | Lupus Erythematosus, Cutaneous | Pemphigus

France
University Hospital, Brest

Completed

Clinical Characteristics of Pruritus and Evaluation of Quality of Life in Patients With Bullous Pemphigoid (PRURIPB)

Bullous Pemphigoid

France
AstraZeneca

Terminated

A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid. (FJORD)

Bullous Pemphigoid

France, Italy, Spain, Germany, United States, Australia, China, Bulgaria, Israel, Japan, Greece
Centre Hospitalier Universitaire de Nice

Not yet recruiting

Peridontal and Intestinal Microbiota in Patients With Gingival Scarring Pemphigoid (MICROPC)

Pemphigoid, Benign Mucous Membrane | Gingivitis Hyperplastic

France
Institut National de la Santé Et de la Recherche...

Recruiting

FARD (RaDiCo Cohort) (RaDiCo-FARD) (FARD)

Neurofibromatosis Type 1 | Ichthyosis | Ectodermal Dysplasia | Albinism | Pemphigus | Mucous Membrane Pemphigoid | Inherited Epidermolysis Bullosa | Palmoplantar Keratoderma | Incontinentia Pigmenti

France
CHU de Reims

Completed

Register of Autoimmune Bullous Dermatoses (REGIBUL)

Autoimmune Bullous Dermatoses

France
University Hospital, Toulouse

Recruiting

Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases (TekAPo)

Skin Diseases | Autoimmune Bullous Dermatosis | Dysimmune Dermatological Diseases | Auto-inflammatory Dermatological Diseases

France
Holostem Terapie Avanzate s.r.l.
IRCCS San Raffaele; University of Modena and Reggio Emilia

Recruiting

Open-label, Pivotal Clinical Trial to Confirm Efficacy and Safety of Autologous Grafts Containing Stem Cells Genetically Modified for Epidermis Restoration in Patients With Junctional Epidermolysis Bullosa (HOLOGENE 5)

Junctional Epidermolysis Bullosa Non-Herlitz Type

France, Italy
Institut National de la Santé Et de la Recherche...

Unknown

Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB) (RDEB)

Recessive Dystrophic Epidermolysis Bullosa

France, United Kingdom
Centre Hospitalier Universitaire de Nice

Completed

Study of Inflammatory Mechanisms in Epidermolysis Bullosa Simplex- Dowling Meara

Epidermolysis Bullosa Simplex Dowling Meara

France
Organ, Tissue, Regeneration, Repair and Replacement
Euraxi Pharma; ARANZ Medical

Recruiting

CACIPLIQ20 in Wound Healing in Subjects With Epidermolysis Bullosa (MATHBULL)

Epidermolysis Bullosa Dystrophica | Epidermolysis Bullosa, Junctional

France
Centre Hospitalier Universitaire de Nice

Recruiting

Gynecological Follow-up of Patients With Dystrophic Epidermolysis Bullosa (EBD)

Dystrophic Epidermolysis Bullosa

France
Institut National de la Santé Et de la Recherche...

Active, not recruiting

Ex Vivo Gene Therapy Clinical Trial for RDEB Using Genetically Corrected Autologous Skin Equivalent Grafts (EBGraft)

Epidermolysis Bullosa Dystrophica, Recessive

France
Centre Hospitalier Universitaire de Nice

Withdrawn

Pilot Study Evaluating the Efficiency and the Tolerance of the PDT in the Treatment of Epidermal Dysplasia for Patients Affected by Hereditary DEB

Dystrophic Epidermolysis Bullosa

France
Assistance Publique - Hôpitaux de Paris

Unknown

A Comparative Study of the Healing of Chronic Ulcers of Recessive Epidermolysis Bullosa : Dressing vs Amniotic Membrane (MABUL)

Ulcer | Epidermolysis Bullosa Dystrophica, Recessive

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Drug Reactions Sampling (COLLECTIONTOXIDERMIES)

Erythema Multiforme | Stevens-Johnson Syndrome | Lyell Syndrome | Drug Reactions | AGEP | DRESS | Bullous Dermatosis Caused by Drug Treatment (Disorder) | Maculopapular Exanthem

France
RHEACELL GmbH & Co. KG
FGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & Services

Completed

Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa

Recessive Dystrophic Epidermolysis Bullosa

United States, Austria, France, Germany, United Kingdom
Phoenicis Therapeutics

Terminated

A Double-blind, Randomized, Intra-subject Placebo-controlled, Multicenter, Multiple Dose Study, Evaluating Safety, Proof of Mechanism, Preliminary Efficacy and Systemic Exposure in Subjects With Confirmed DDEB or RDEB Diagnosis With One or More Pathogenic Mutations in Exon 73 in the COL7A1 Gene

Epidermolysis Bullosa Dystrophica, Recessive | Epidermolysis Bullosa Dystrophica, Dominant

United States, Spain, France
Assistance Publique - Hôpitaux de Paris
Fondation Apicil; HELEBOR; Lions Club International Foundation

Completed

Evaluation of the Efficacy of CANNABIDIOL on the Pruritus in Children With Hereditary Epidermolysis Bullosa (EBCBD)

Hereditary Epidermolysis Bullosa

France
InMed Pharmaceuticals Inc.

Completed

INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa

Epidermolysis Bullosa Dystrophica | Epidermolysis Bullosa Simplex | Epidermolysis Bullosa, Junctional | Kindler Syndrome

France, Germany, Greece, Israel, Italy
Centre Hospitalier Universitaire de Nice

Unknown

Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral Erythromycin

Epidermolysis Bullosa

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Impact of Complex Care Training of Hereditary Epidermolysis Bullosa on Caregiver Burden (FIREB) (FIREB)

Hereditary Epidermolysis Bullosa

France
Centre Hospitalier Universitaire de Nice

Completed

Treatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate)

Epidermolysis Bullosa Dystrophica

France
University Hospital, Toulouse

Recruiting

Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex (EBTox)

Epidermolysis Bullosa Simplex

France
Shire

Completed

Short Term Observational Study in DEB Patients

Dystrophic Epidermolysis Bullosa

United States, Czechia, Italy, Austria, Australia, France, Germany
Centre Hospitalier Régional Metz-Thionville

Completed

Predictive Factors of Graft Detachment Following Dmek (PDF DMEKDETACH)

Pseudophakic Bullous Keratopathy | Fuchs' Endothelial Corneal Dystrophy | Descemet Membrane Endothelial Keratoplasty | Graft Detachment

France
Assistance Publique - Hôpitaux de Paris

Completed

Evaluation of the Efficacy of ROPIVACAINE in Children and Young Adults With Hereditary Epidermolysis Bullosa (EBROPI)

Epidermolysis Bullosa

France
Assistance Publique - Hôpitaux de Paris

Completed

Improve Adherence to Weak or Strong Opioid Analgesics at the Time of Care in Children With Hereditary Epidermolysis Bullosa (ODEB)

Epidermolysis Bullosa

France

Clinical Trials on Bullous Pemphigoid in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations